Mobia Medical, Inc. Common Stock (MOBI) EBITDA Yield: History & Chart

Mobia Medical, Inc. Common Stock(MOBI)

Medical - Specialties · Austin, TX

$9.27-0.32 (-3.39%)

Delayed quote: Oct 6, 2026, 10:34 AM EDT

About Mobia Medical, Inc. Common Stock

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.

Austin, TX

167 employees

www.mobia.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Richard Foust

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Mobia Medical, Inc. Common Stock (MOBI)	$308.05M	N/A	N/A	N/A	N/A
Benitec Biopharma Inc. (BNTC)vs ›	$306.01M	N/A	6.62%	6.62%	6.62%
CapsoVision, Inc. (CV)vs ›	$317.27M	N/A	N/A	N/A	N/A
C4 Therapeutics, Inc. (CCCC)vs ›	$321.20M	N/A	N/A	N/A	N/A
Cabaletta Bio, Inc. (CABA)vs ›	$320.65M	N/A	N/A	N/A	N/A
Standard BioTools Inc. (LAB)vs ›	$291.99M	N/A	N/A	N/A	N/A
BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›	$285.18M	N/A	N/A	N/A	N/A
Larimar Therapeutics, Inc. (LRMR)vs ›	$286.44M	N/A	N/A	N/A	N/A
Agenus Inc. (AGEN)vs ›	$331.68M	11.57%	6.91%	6.91%	10.15%
ClearPoint Neuro, Inc. (CLPT)vs ›	$333.18M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

Mobia Medical, Inc. Common Stock (MOBI)

$308.05M

N/A

Benitec Biopharma Inc. (BNTC)vs ›

$306.01M

N/A

6.62%

CapsoVision, Inc. (CV)vs ›

$317.27M

N/A

C4 Therapeutics, Inc. (CCCC)vs ›

$321.20M

N/A

Cabaletta Bio, Inc. (CABA)vs ›

$320.65M

N/A

Standard BioTools Inc. (LAB)vs ›

$291.99M

N/A

BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›

$285.18M

N/A

Larimar Therapeutics, Inc. (LRMR)vs ›

$286.44M

N/A

Agenus Inc. (AGEN)vs ›

$331.68M

11.57%

6.91%

10.15%

ClearPoint Neuro, Inc. (CLPT)vs ›

$333.18M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

MOBI EBITDA Yield Metrics

MOBI Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics